MedPath

A clinical trial to study the pain relief effect of two local anesthetic drugs ropivacaine and bupivacaine given to block the nerves located in abdominal wall after caesarean section.

Phase 4
Not yet recruiting
Conditions
Encounter for cesarean delivery without indication,
Registration Number
CTRI/2018/10/015979
Lead Sponsor
Dr Aniket Kakade
Brief Summary

This is a randomized, double blind, parallel group trial to compare the efficacy of ropivacaine versus bupivacaine during surgical transversus abdominis plane [TAP]block for post-operative analgesia after caesarean section. Surgical TAP block is a established technique used for post operative analgesia. we plan to compare two drugs in 100 patients who require caesarean section. The post operative pain will be assessed by using the visual analogue scale [VAS] and the duration of analgesia in hours after giving the drug by TAP block will be assessed. Rescue analgesia will be administered to all those patients who complain of pain at VAS 3. The secondary outcome will be study of any side effects of the drugs.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

all patients who require caesarean delivery.

Exclusion Criteria

Patient with ASA III or above Any allergy to used drug Local infection at the site of block Patients requiring vertical abdominal incision and upper segment caesarean section Patients requiring general anesthesia Height of patient less than 150 cms and more than 180 cms (as these patients will require a different dosage of spinal anaesthesia) Patients with thrombocytopenia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome Name: Post operative pain relief. To be assessed by Visual Analogue score [VAS]Time Point: One hourly assessment for 8 hours
Secondary Outcome Measures
NameTimeMethod
Outcome Name: Side effects of the drugsTime Points: Every hour assessment in post operative period for 24 hours.

Trial Locations

Locations (1)

Bharati Hospital & Research Center

🇮🇳

Pune, MAHARASHTRA, India

Bharati Hospital & Research Center
🇮🇳Pune, MAHARASHTRA, India
Dr Aniket Kakade
Principal investigator
9850988568
aniket1kakade@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.